The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol

Table 1 Inclusion and exclusion criteria

Inclusion criteria	Exclusion criteria
○ Age ≥ 18 years	○ Irreversible bleeding disorders
○ Solid enhancing mass on cross sectional imaging	○ Inability to stop anticoagulation therapy
○ Scheduled for open or laparoscopic RN	○ Prev. cryoablation, RFA or PN affected kidney
○ Signed informed consent	○ Anaesthesia Surgical Assignment (ASA) cat. ≤ IV
	○ ICD or pacemaker
	○ Severe cardiovascular disease

Severe cardiovascular disease is defined as the diagnosis of myocardial infarction, uncontrolled angina, significant ventricular arrhythmias, stroke or severe cardiac failure (NYHA class ≥ III) within 6 months prior to inclusion.

ISSN: 1471-2407